ROC curves comparison (with their corresponding AUC) for age, Ca_Tot, C2-carnitine, C10:2-Carnitine, C18-Carnitine and the logistic algorithm in the estimation of survival prognosis.

<p>Abbreviation: AUC = area under the curve.</p

Results of the clinical examination of horses with atypical myopathy.

<p>Results of the clinical examination of horses with atypical myopathy.</p

Best prognostic predictors in the four principal components of a clinical approach.

<p>Best prognostic predictors in the four principal components of a clinical approach.</p

Mean age and frequency distribution of demographic data of horses with atypical myopathy.

<p>Mean age and frequency distribution of demographic data of horses with atypical myopathy.</p

Frequency distribution of clinical signs in horses with atypical myopathy.

<p>Frequency distribution of clinical signs in horses with atypical myopathy.</p

Survival prognosis estimated on independent cohort of horses with atypical myopathy [17, 18].

<p>Prognosis varies from 0 to 1; the closer the value is to zero, the higher the risk of mortality. Conversely, the closer the value approaches 1, the greater the chance of survival. Low mortality risk is marked in bold.</p

Results of the clinical examination of horses with atypical myopathy.

<p>Results of the clinical examination of horses with atypical myopathy.</p

Serum (mean ±SD) concentrations of free carnitine and acylcarnitines (μmol/L) in horses with atypical myopathy and control horses.

<p>Serum (mean ±SD) concentrations of free carnitine and acylcarnitines (μmol/L) in horses with atypical myopathy and control horses.</p

Biochemical and haematological findings in horses with atypical myopathy (Mean ±SD).

<p>Biochemical and haematological findings in horses with atypical myopathy (Mean ±SD).</p